Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy

Esophageal cancer is a malignant neoplasm developed in the esophagus; it is the tenth most common type of cancer and sixth most common cause of cancer mortality worldwide [1]. In addition, squamous cell cancer is the most frequently diagnosed histological subtype, and it is related to risk factors such as smoking and alcohol consumption [2 –4]. Surgery resection, endoscopic resection, radiotherapy, chemotherapy, and concurrent chemoradiotherapy (CCRT) are treatments selected depending on the clinical stage, tumor location, and patient’s condition [3,5,6].

Source: Physica Medica: European Journal of Medical Physics - December 11, 2023 Category: General Medicine Authors: Takahiro Nakamoto, Hideomi Yamashita, Haruka Jinnouchi, Kanabu Nawa, Toshikazu Imae, Shigeharu Takenaka, Atsushi Aoki, Takeshi Ohta, Sho Ozaki, Yuki Nozawa, Keiichi Nakagawa Source Type: research